SB-202190
SB 202190 is a potent, cell-permeable, and selective inhibitor of p38α and p38β2 MAP kinases. This compound is widely used in research to study inflammation, apoptosis, and cellular stress responses, and it has demonstrated utility in both in vitro models, such as stem cell differentiation into cardiomyocytes, and in vivo antitumor studies.
Product Specifications
CAS Number
152121-30-7
Product Name Alternative
P38α, p38β, p38MAPK, pocket, p38 MAPK, spatial, SB 202190, SB202190, SB-202190, deficits, colorectal, Autophagy, ATP, Apoptosis, anti-cancer, FHPI, Inhibitor, memory, learning, inhibit
Field of Research
Cell Biology, Stem Cell & Developmental Biology
Purity
>98%
Bioactivity
P38 MAP kinase inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 30 mg/ml) .
Smiles
Oc1ccc (cc1) -c1nc (c ([nH]1) -c1ccc (F) cc1) -c1ccncc1
Molecular Formula
C20H14N3OF
Molecular Weight
331.35
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[4- (4-Fluorophenyl) -5- (4-pyridiny¬l) -1H-imidazol-2-yl]phenol
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Yyj2835-inquire Inquire
Recombinant Mycobacterium Bovis cdh Protein (aa 1-260) (strain BCG / Pasteur 1173P2)
Sign In for Pricing
View Details 